GT Biopharma Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| 05/15/2026 | 451.88 K | $184.37 K | 100.00% | 8.20% | |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 294.46 K | $120.17 K | 1,429.02% | 5.34% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 225.94 K | $92.18 K | 100.00% | 4.10% |
| SRS CAPITAL ADVISORS, INC. | 05/13/2026 | 93.63 K | $38.21 K | 100.00% | 1.70% |
| CITADEL ADVISORS LLC | 05/15/2026 | 66.17 K | $27.00 K | -18.07% | 1.20% |
| SEACREST WEALTH MANAGEMENT, LLC | 04/15/2026 | 50.00 K | $20.41 K | 0.00% | 0.91% |
| UBS GROUP AG | 05/05/2026 | 45.97 K | $18.76 K | 4,596,900.00% | 0.83% |
| TWO SIGMA SECURITIES, LLC | 05/15/2026 | 31.80 K | $12.98 K | 153.68% | 0.58% |
| LPL FINANCIAL LLC | 05/06/2026 | 30.38 K | $12.40 K | 185.76% | 0.55% |
| INVST, LLC | 05/13/2026 | 23.40 K | $9.55 K | 100.00% | 0.42% |
| ADVISOR GROUP HOLDINGS, INC. | 05/15/2026 | 21.00 K | $8.57 K | 950.00% | 0.38% |
| KEEL POINT, LLC | 06/01/2026 | 20.77 K | $8.48 K | 100.00% | 0.38% |
| CERITY PARTNERS LLC | 05/15/2026 | 20.02 K | $8.17 K | 33.49% | 0.36% |
| INTEGRATED WEALTH CONCEPTS LLC | 05/15/2026 | 20.01 K | $8.16 K | 0.00% | 0.36% |
| PRIVATE WEALTH MANAGEMENT GROUP, LLC | 04/23/2026 | 20.00 K | $8.16 K | 100.00% | 0.36% |
| COSTON, MCISAAC & PARTNERS | 04/22/2026 | 17.09 K | $6.00 K | 0.00% | 0.31% |
| MORGAN STANLEY | 05/15/2026 | 16.60 K | $6.77 K | -10.75% | 0.30% |
| CAITLIN JOHN, LLC | 05/13/2026 | 16.50 K | $6.73 K | 0.00% | 0.30% |
| WELLS FARGO & COMPANY/MN | 05/11/2026 | 16.04 K | $6.55 K | 0.00% | 0.29% |
| AM INVESTMENT STRATEGIES LLC | 04/29/2026 | 15.00 K | $6.00 K | 0.00% | 0.27% |
| VIRTU FINANCIAL LLC | 05/14/2026 | 14.88 K | $6.00 K | 100.00% | 0.27% |
| STONEX GROUP INC. | 05/14/2026 | 14.76 K | $6.02 K | 100.00% | 0.27% |
| VERDENCE CAPITAL ADVISORS LLC | 04/30/2026 | 12.00 K | $4.90 K | -7.69% | 0.22% |
| PROSPERA FINANCIAL SERVICES INC | 04/14/2026 | 12.00 K | $4.89 K | 0.00% | 0.22% |
| LASALLE ST. INVESTMENT ADVISORS, LLC | 05/08/2026 | 11.00 K | $4.49 K | 100.00% | 0.20% |
| PARSONS CAPITAL MANAGEMENT INC/RI | 04/15/2026 | 10.90 K | $4.45 K | 0.00% | 0.20% |
| HBK SORCE ADVISORY LLC | 05/11/2026 | 10.00 K | $3.75 K | 0.00% | 0.18% |
| BLACKROCK, INC. | 05/13/2026 | 8.41 K | $3.43 K | -0.01% | 0.15% |
| ALLWORTH FINANCIAL LP | 05/15/2026 | 4.50 K | $1.84 K | 450,000.00% | 0.08% |
| NEWBRIDGE FINANCIAL SERVICES GROUP, INC. | 05/05/2026 | 3.75 K | $1.53 K | 0.00% | 0.07% |
| FARTHER FINANCE ADVISORS, LLC | 04/07/2026 | 3.00 K | $1.23 K | 0.00% | 0.05% |
| MASSMUTUAL TRUST CO FSB/ADV | 04/13/2026 | 3.00 K | $1.22 K | 100.00% | 0.05% |
| WEST FINANCIAL ADVISORS, LLC | 04/08/2026 | 2.50 K | $1.02 K | 100.00% | 0.05% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2026 | 1.70 K | $693 | -0.18% | 0.03% |
| TRIUMPH CAPITAL MANAGEMENT | 05/13/2026 | 1.66 K | $675 | 0.00% | 0.03% |
| STONE HOUSE INVESTMENT MANAGEMENT, LLC | 04/22/2026 | 1.25 K | $510 | 100.00% | 0.02% |
| FMR LLC | 05/15/2026 | 1.00 K | $408 | 100.00% | 0.02% |
| HILLTOP NATIONAL BANK | 04/02/2026 | 100 | $41 | 100.00% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 05/12/2026 | 16 | $7 | 0.00% | 0.00% |
| JPMORGAN CHASE & CO | 05/13/2026 | 0 | $0 | -100.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 0 | $0 | -100.00% | 0.00% |
| CITIGROUP INC | 05/11/2026 | 0 | $0 | -100.00% | 0.00% |
| BANK OF MONTREAL /CAN/ | 05/13/2026 | 0 | $0 | -100.00% | 0.00% |
| HRT FINANCIAL LP | 05/14/2026 | 0 | $0 | -100.00% | 0.00% |
| ADVISORY SERVICES NETWORK, LLC | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| JANE STREET GROUP, LLC | 05/12/2026 | 0 | $0 | -100.00% | 0.00% |
| WOLFF WIESE MAGANA LLC | 04/13/2026 | 0 | $0 | -100.00% | 0.00% |
| SBI SECURITIES CO., LTD. | 04/28/2026 | 0 | $0 | -100.00% | 0.00% |
| SPIRE WEALTH MANAGEMENT | 04/22/2026 | 0 | $0 | -100.00% | 0.00% |
| SWAN CAPITAL LLC | 05/14/2026 | 0 | $0 | -100.00% | 0.00% |
GT Biopharma Inc institutional Ownership - FAQ's
During the previous two years, 58 institutional investors and hedge funds held shares of GT Biopharma Inc. The most heavily invested institutionals were:
GEODE CAPITAL MANAGEMENT, LLC: 294,459
VANGUARD FIDUCIARY TRUST CO: 225,938
SRS Capital Advisors, Inc.: 93,627
CITADEL ADVISORS LLC: 66,165
SeaCrest Wealth Management, LLC: 50,000
UBS Group AG: 45,970
29.26% of GT Biopharma Inc stock is owned by institutional investors.
Institutional investors have bought a total of 1.18 M shares in the last 24 months. This purchase volume represents approximately $494.11 K in transactions.